Trials / Completed
CompletedNCT06215287
Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this survey is to assess the knowledge of HCPs in relation to the recommended posology and biological monitoring for Exjade, based on the current locally valid Exjade educational materials (including the physician's reference checklist)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physician survey | Survey to assess physicians' knowledge of Exjade posology and biological monitoring recommendations as described in the Educational Materials |
Timeline
- Start date
- 2024-01-12
- Primary completion
- 2024-02-15
- Completion
- 2024-02-15
- First posted
- 2024-01-22
- Last updated
- 2024-05-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06215287. Inclusion in this directory is not an endorsement.